210 related articles for article (PubMed ID: 23223198)
21. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T; Adriani M; Jagadeesh GJ; Paine A; Candotti F
Mol Ther; 2012 Jun; 20(6):1270-9. PubMed ID: 22215016
[TBL] [Abstract][Full Text] [Related]
22. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
23. In vivo selection of hematopoietic stem cells transduced at a low multiplicity-of-infection with a foamy viral MGMT(P140K) vector.
Cai S; Ernstberger A; Wang H; Bailey BJ; Hartwell JR; Sinn AL; Eckermann O; Linka Y; Goebel WS; Hanenberg H; Pollok KE
Exp Hematol; 2008 Mar; 36(3):283-92. PubMed ID: 18279716
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection.
Richard E; Robert E; Cario-André M; Ged C; Géronimi F; Gerson SL; de Verneuil H; Moreau-Gaudry F
Gene Ther; 2004 Nov; 11(22):1638-47. PubMed ID: 15284838
[TBL] [Abstract][Full Text] [Related]
25. Production of foamy virus vector and transduction of hematopoietic cells.
Josephson NC; Russell DW
Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5481. PubMed ID: 20810629
[TBL] [Abstract][Full Text] [Related]
26. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.
Josephson NC; Trobridge G; Russell DW
Hum Gene Ther; 2004 Jan; 15(1):87-92. PubMed ID: 14965380
[TBL] [Abstract][Full Text] [Related]
27. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Ohmine K; Li Y; Bauer TR; Hickstein DD; Russell DW
Hum Gene Ther; 2011 Feb; 22(2):217-24. PubMed ID: 20738155
[TBL] [Abstract][Full Text] [Related]
28. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
Simantirakis E; Tsironis I; Vassilopoulos G
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
[TBL] [Abstract][Full Text] [Related]
29. Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors.
Enssle J; Trobridge GD; Keyser KA; Ironside C; Beard BC; Kiem HP
Hum Gene Ther; 2010 Apr; 21(4):397-403. PubMed ID: 19947827
[TBL] [Abstract][Full Text] [Related]
30. A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.
Everson EM; Olzsko ME; Leap DJ; Hocum JD; Trobridge GD
Mol Ther Methods Clin Dev; 2016; 3():16048. PubMed ID: 27579335
[TBL] [Abstract][Full Text] [Related]
31. In-Vivo Gene Therapy with Foamy Virus Vectors.
Rajawat YS; Humbert O; Kiem HP
Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
[TBL] [Abstract][Full Text] [Related]
32. Foamy virus as a gene transfer vector to the central nervous system.
Caprariello AV; Miller RH; Selkirk SM
Gene Ther; 2009 Mar; 16(3):448-52. PubMed ID: 19052632
[TBL] [Abstract][Full Text] [Related]
33. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
34.
Rajawat YS; Humbert O; Cook SM; Radtke S; Pande D; Enstrom M; Wohlfahrt ME; Kiem HP
Hum Gene Ther; 2021 Jan; 32(1-2):113-127. PubMed ID: 32741228
[TBL] [Abstract][Full Text] [Related]
35. Feline foamy virus-based vectors: advantages of an authentic animal model.
Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
[TBL] [Abstract][Full Text] [Related]
37. Efficient liver gene transfer with foamy virus vectors.
Zacharoulis D; Rountas C; Katsimpoulas M; Morianos J; Chatziandreou I; Vassilopoulos G
Med Sci Monit Basic Res; 2013 Aug; 19():214-20. PubMed ID: 23941977
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.
Chinnasamy D; Fairbairn LJ; Neuenfeldt J; Treisman JS; Hanson JP; Margison GP; Chinnasamy N
Hum Gene Ther; 2004 Aug; 15(8):758-69. PubMed ID: 15319033
[TBL] [Abstract][Full Text] [Related]
39. Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes.
Hocum JD; Linde I; Rae DT; Collins CP; Matern LK; Trobridge GD
Sci Rep; 2016 Nov; 6():36610. PubMed ID: 27812034
[TBL] [Abstract][Full Text] [Related]
40. The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells.
Sellers SE; Tisdale JF; Agricola BA; Metzger ME; Donahue RE; Dunbar CE; Sorrentino BP
Blood; 2001 Mar; 97(6):1888-91. PubMed ID: 11238136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]